Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?-Reference-Cited by-同舟云学术

Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?

Published:2019-03-21 Issue:7 Volume:29 Page:3935-3944
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Kitajima Kazuhiro,Okada Masaya,Kashiwagi Toru,Yoshihara Kyoko,Tokugawa Tazuko,Sawada Akihiro,Yoshihara Satoshi,Fujimori Yoshihiro,Yamakado Koichiro

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06134-7.pdf

Reference19 articles.

1. Wagner HN Jr, Wiseman GA, Marcus CS et al (2002) Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. J Nucl Med 43:267–272

2. Witzig TE, Gordon LI, Cabanillas F et al (2002) Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma. J Clin Oncol 20:2453–2463

3. Kaminski MS, Tuck M, Estes J et al (2005) 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 352:441–449

4. Illidge TM, Mayes S, Pettengell R et al (2014) Fractionated 90Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria. J Clin Oncol 32:212–218

5. McQuillan AD, Macdonald WB, Turner JH (2015) Phase II study of first-line 131I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic 18F-fluorodeoxyglucose positron emission tomography. Leuk Lymphoma 56:1271–1277

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Therapy of Lymphomas;Nuclear Oncology;2022

2. Radionuclide Therapy of Lymphomas;Nuclear Oncology;2022

3. Radionuclide Therapy of Lymphomas;Nuclear Oncology;2022

4. The Use of PET in Evaluating the Efficacy of Immunotherapy in Oncology;Nuclear Medicine and Immunology;2021-11-25

5. Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation;Clinical and Translational Oncology;2021-01-15